SG Americas Securities
RLYB icon

SG Americas Securities’s Rallybio RLYB Stock Holding History

SG Americas Securities’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,321
Closed -$20K – 3246
2024
Q1 		$20K Sell
1,321
-781
-37% -$10.9K ﹤0.01% 2863
2023
Q4 		$40K Buy
+2,102
New +$51.4K ﹤0.01% 2952

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SG Americas Securities's RLYB Position: Q2 2024 in Review

SG Americas Securities sold out of Rallybio (RLYB) in Q2 2024, closing a stake of 1,321 shares — an estimated $20K sold.

SG Americas Securities first reported a position in RLYB in Q4 2023 and held it in 2 quarters. The position peaked at $40K in Q4 2023. 66 funds tracked by Wall St. Rank hold RLYB as of Q2 2024.

  • SG Americas Securities reported no remaining Rallybio position as of Q2 2024 after selling out during the quarter.
  • SG Americas Securities sold 1,321 Rallybio shares in Q2 2024, an estimated $20K.
  • SG Americas Securities first reported a position in Rallybio in Q4 2023 and held it in 2 quarters.
  • SG Americas Securities's Rallybio position peaked at $40K in Q4 2023.
  • 66 funds tracked by Wall St. Rank held Rallybio as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.